Role and possible mechanisms of clenbuterol in enhancing reverse remodelling during mechanical unloading in murine heart failure

Cardiovascular Research

Volumn 77, Issue 4, 2008, Pages 695-706

  Soppa, Gopal K R ^a   Lee, Joon ^a   Stagg, Mark A ^a   Felkin, Leanne E ^a   Barton, Paul J R ^a   Siedlecka, Urszula ^a   Youssef, Samuel ^a   Yacoub, Magdi H ^a   Terracciano, Cesare M N ^a  

^a HAREFIELD HOSPITAL   (United Kingdom)

Author keywords

Calcium; Clenbuterol; Heart failure; Myofilament sensitivity; Unloading

Indexed keywords

CALCIUM; CALCIUM CHANNEL L TYPE; CLENBUTEROL; MYOSIN HEAVY CHAIN; SODIUM CALCIUM EXCHANGE PROTEIN; SODIUM CHLORIDE;

ACTION POTENTIAL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM CURRENT; CELL ISOLATION; CELL STRUCTURE; CHEMOSENSITIVITY; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DRUG EFFECT; DRUG MECHANISM; ECHOCARDIOGRAPHY; ELECTROPHYSIOLOGY; FLUORESCENCE; GRAFT RECIPIENT; HEART FAILURE; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART TRANSPLANTATION; HETEROTOPIC TRANSPLANTATION; HYSTERESIS; IN VIVO STUDY; LEFT CORONARY ARTERY; LEWIS RAT; LINEAR SYSTEM; MALE; MYOFILAMENT; NONHUMAN; OSMOTIC MINIPUMP; PRIORITY JOURNAL; RAT; SARCOMERE; SODIUM CURRENT; STATISTICAL SIGNIFICANCE;

ACTION POTENTIALS; ADRENERGIC BETA-AGONISTS; ANIMALS; CALCIUM CHANNELS, L-TYPE; CALCIUM SIGNALING; CELL SIZE; CLENBUTEROL; DISEASE MODELS, ANIMAL; HEART FAILURE; HEART TRANSPLANTATION; INFUSION PUMPS, IMPLANTABLE; MALE; MICE; MICROFILAMENTS; MYOCARDIAL CONTRACTION; MYOCARDIUM; MYOCYTES, CARDIAC; MYOSIN HEAVY CHAINS; PROTEIN ISOFORMS; RATS; RATS, INBRED LEW; RECEPTORS, ADRENERGIC, BETA-2; SARCOMERES; SODIUM-CALCIUM EXCHANGER; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 39749171161     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvm106     Document Type: Article

References (54)

1. Jessup M, Brozena S. Heart failure. N Engl J Med 2003;348:2007-2018.
2. Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W et al. Long-term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med 2001;345:1435-1443.
3. Clegg AJ, Scott DA, Loveman E, Colquitt JL, Royle P, Bryant J. Clinical and cost-effectiveness of left ventricular assist devices as a bridge to heart transplantation for people with end-stage heart failure: a systematic review and economic evaluation. Eur Heart J 2006;27:2929-2938.
4. Frazier OH, Myers TJ. Left ventricular assist system as a bridge to myocardial recovery. Ann Thorac Surg 1999;68:734-741.
5. Dandel M, Weng Y, Siniawski H, Potapov E, Lehmkuhl HB, Hetzer R. Long-term results in patients with idiopathic dilated cardiomyopathy after weaning from left ventricular assist devices. Circulation 2005;112:I37-I45.
6. Mancini DM, Beniaminovitz A, Levin H, Catanese K, Flannery M, DiTullio M et al. Low incidence of myocardial recovery after left ventricular assist device implantation in patients with chronic heart failure. Circulation 1998;98:2383-2389.
7. Maybaum S, Mancini D, Xydas S, Starling RC, Aaronson K, Pagani FD et al. Cardiac improvement during mechanical circulatory support: a prospective multicenter study of the LVAD Working Group. Circulation 2007;115:2497-2505.
8. Wohlschlaeger J, Schmitz KJ, Schmid C, Schmid KW, Keul P, Takeda A et al. Reverse remodeling following insertion of left ventricular assist devices (LVAD): a review of the morphological and molecular changes. Cardiovasc Res 2005;68:376-386.
9. Ito K, Nakayama M, Hasan F, Yan X, Schneider MD, Lorell BH. Contractile reserve and calcium regulation are depressed in myocytes from chronically unloaded hearts. Circulation 2003;107:1176-1182.
10. Yacoub MH. A novel strategy to maximize the efficacy of left ventricular assist devices as a bridge to recovery. Eur Heart J 2001;22:534- 540.
11. Birks EJ, Tansley PD, Hardy J, George RS, Bowles CT, Burke M et al. Left ventricular assist device and drug therapy for the reversal of heart failure. N Engl J Med 2006;355:1873-1884.
12. George I, Xydas S, Mancini DM, Lamanca J, DiTullio M, Marboe CC et al. Effect of clenbuterol on cardiac and skeletal muscle function during left ventricular assist device support. J Heart Lung Transplant 2006;25:1084-1090.
13. Soppa GK, Smolenski RT, Latif N, Yuen AH, Malik A, Karbowska J et al. Effects of chronic administration of clenbuterol on function and metabolism of adult rat cardiac muscle. Am J Physiol Heart Circ Physiol 2005;288:H1468-H1476.
14. Petrou M, Wynne DG, Boheler KR, Yacoub MH. Clenbuterol induces hypertrophy of the latissimus dorsi muscle and heart in the rat with molecular and phenotypic changes. Circulation 1995;92:II483-II489.
15. Wong K, Boheler KR, Bishop J, Petrou M, Yacoub MH. Clenbuterol induces cardiac hypertrophy with normal functional, morphological and molecular features. Cardiovasc Res 1998;37:115-122.
16. Wong K, Boheler KR, Petrou M, Yacoub MH. Pharmacological modulation of pressure-overload cardiac hypertrophy: changes in ventricular function, extracellular matrix, and gene expression. Circulation 1997;96:2239-2246.
17. Hon JK, Steendijk P, Petrou M, Wong K, Yacoub MH. Influence of clenbuterol treatment during six weeks of chronic right ventricular pressure overload as studied with pressure-volume analysis. J Thorac Cardiovasc Surg 2001;122:767-774.
18. Petrou M, Clarke S, Morrison K, Bowles C, Dunn M, Yacoub M. Clenbuterol increases stroke power and contractile speed of skeletal muscle for cardiac assist. Circulation 1999;99:713-720.
19. Xydas S, Kherani AR, Chang JS, Klotz S, Hay I, Mutrie CJ et al. {beta}-2 Adrenergic stimulation attenuates left ventricular remodeling, decreases apoptosis, and improves calcium homeostasis in a rodent model of ischemic cardiomyopathy. J Pharmacol Exp Ther 2006;317:553-561.
20. Tsuneyoshi H, Oriyanhan W, Kanemitsu H, Shiina R, Nishina T, Matsuoka S et al. Does the beta2-agonist clenbuterol help to maintain myocardial potential to recover during mechanical unloading? Circulation 2005;112:I51-I56.
21. Margulies KB. Reversal mechanisms of left ventricular remodeling: lessons from left ventricular assist device experiments. J Card Fail 2002;8:S500-S505.
22. Loennechen JP, Wisloff U, Falck G, Ellingsen O. Cardiomyocyte contractility and calcium handling partially recover after early deterioration during post-infarction failure in rat. Acta Physiol Scand 2002;176:17-26.
23. Ahmet I, Krawczyk M, Heller P, Moon C, Lakatta EG, Talan MI. Beneficial effects of chronic pharmacological manipulation of beta-adrenoreceptor subtype signaling in rodent dilated ischemic cardiomyopathy. Circulation 2004;110:1083-1090.
24. Yang XP, Liu YH, Rhaleb NE, Kurihara N, Kim HE, Carretero OA. Echocardiographic assessment of cardiac function in conscious and anesthetized mice. Am J Physiol 1999;277:H1967-H1974.
25. Ono K, Lindsey ES. Improved technique of heart transplantation in rats. J Thorac Cardiovasc Surg 1969;57:225-229.
26. Smolenski RT, Raisky O, Slominska EM, Abunasra H, Kalsi KK, Jayakumar J et al. Protection from reperfusion injury after cardiac transplantation by inhibition of adenosine metabolism and nucleotide precursor supply. Circulation 2001;104:I246-I252.
27. Hering S, Bodewei R, Wollenberger A. Sodium current in freshly isolated and in cultured single rat myocardial cells: frequency and voltage-dependent block by mexiletine. J Mol Cell Cardiol 1983;15:431-444.
28. Bailey BA, Dipla K, Li S, Houser SR. Cellular basis of contractile derangements of hypertrophied feline ventricular myocytes. J Mol Cell Cardiol 1997;29:1823-1835.
29. Terracciano CM, Hardy J, Birks EJ, Khaghani A, Banner NR, Yacoub MH. Clinical recovery from end-stage heart failure using left-ventricular assist device and pharmacological therapy correlates with increased sarcoplasmic reticulum calcium content but not with regression of cellular hypertrophy. Circulation 2004;109:2263-2265.
30. Terracciano CM, Tweedie D, MacLeod KT. The effects of changes to action potential duration on the calcium content of the sarcoplasmic reticulum in isolated guinea-pig ventricular myocytes. Pflugers Arch 1997;433:542-544.
31. Keung EC, Toll L, Ellis M, Jensen RA. L-type cardiac calcium channels in doxorubicin cardiomyopathy in rats morphological, biochemical, and functional correlations. J Clin Invest 1991;87:2108-2113.
32. Felkin LE, Birks EJ, George R, Wong S, Khaghani A, Yacoub MH et al. A quantitative gene expression profile of matrix metalloproteinases (MMPS) and their inhibitors (TIMPS) in the myocardium of patients with deteriorating heart failure requiring left ventricular assist device support. J Heart Lung Transplant 2006;25:1413-1419.
33. Gupta MP. Factors controlling cardiac myosin-isoform shift during hypertrophy and heart failure. J Mol Cell Cardiol 2007;43:388-403.
34. Oriyanhan W, Tsuneyoshi H, Nishina T, Matsuoka S, Ikeda T, Komeda M. Determination of optimal duration of mechanical unloading for failing hearts to achieve bridge to recovery in a rat heterotopic heart transplantation model. J Heart Lung Transplant 2007;26:16-23.
35. Lohse MJ, Engelhardt S, Eschenhagen T. What is the role of beta-adrenergic signaling in heart failure? Circ Res 2003;93:896- 906.
36. Ahmet I, Lakatta EG, Talan MI. Pharmacological stimulation of beta (2)-adrenergic receptors (beta (2)AR) enhances therapeutic effectiveness of beta (1)AR blockade in rodent dilated ischemic cardiomyopathy. Heart Fail Rev 2005;10:289-296.
37. Siedlecka U, Arora M, Soppa GKR, Lee J, Stagg MA, Harding SE et al. Clenbuterol affects rat ventricular myocyte contractility via an inhibitory G protein-mediated pathway. J Mol Cell Cardiol 2007;42:S49 (Abstract).
38. Ogletree-Hughes ML, Stull LB, Sweet WE, Smedira NG, McCarthy PM, Moravec CS. Mechanical unloading restores beta-adrenergic responsiveness and reverses receptor downregulation in the failing human heart. Circulation 2001;104:881-886.
39. Tsuneyoshi H, Oriyanhan W, Kanemitsu H, Shiina R, Nishina T, Ikeda T et al. Heterotopic transplantation of the failing rat heart as a model of left ventricular mechanical unloading toward recovery. ASAIO J 2005;51:116-120.
40. Tevaearai HT, Eckhart AD, Walton GB, Keys JR, Wilson K, Koch WJ. Myocardial gene transfer and overexpression of beta2-adrenergic receptors potentiates the functional recovery of unloaded failing hearts. Circulation 2002;106:124-129.
41. Burniston JG, Tan LB, Goldspink DF. Beta2-adrenergic receptor stimulation in vivo induces apoptosis in the rat heart and soleus muscle. J Appl Physiol 2005;98:1379-1386.
42. Rakusan K, Heron MI, Kolar F, Korecky B. Transplantation-induced atrophy of normal and hypertrophic rat hearts: effect on cardiac myocytes and capillaries. J Mol Cell Cardiol 1997;29:1045-1054.
43. Ghorayeb N, Batlouni M, Pinto IM, Dioguardi GS. Left ventricular hypertrophy of athletes: adaptative physiologic response of the heart. Arq Bras Cardiol 2005;85:191-197.
44. Kong SW, Bodyak N, Yue P, Liu Z, Brown J, Izumo S et al. Genetic expression profiles during physiological and pathological cardiac hypertrophy and heart failure in rats. Physiol Genomics 2005;21:34-42.
45. Gwathmey JK, Copelas L, MacKinnon R, Schoen FJ, Feldman MD, Grossman W et al. Abnormal intracellular calcium handling in myocardium from patients with end-stage heart failure. Circ Res 1987;61:70-76.
46. Li P, Park C, Micheletti R, Li B, Cheng W, Sonnenblick EH et al. Myocyte performance during evolution of myocardial infarction in rats: effects of propionyl-L-carnitine. Am J Physiol 1995;268:H1702-H1713.
47. Anand IS, Liu D, Chugh SS, Prahash AJ, Gupta S, John R et al. Isolated myocyte contractile function is normal in postinfarct remodeled rat heart with systolic dysfunction. Circulation 1997;96:3974-3984.
48. Vahl CF, Bonz A, Timek T, Hagl S. Intracellular calcium transient of working human myocardium of seven patients transplanted for congestive heart failure. Circ Res 1994;74:952-958.
49. Bers DM, Despa S, Bossuyt J. Regulation of Ca2+ and Na+ in normal and failing cardiac myocytes. Ann N Y Acad Sci 2006;1080:165-177.
50. Pieske B, Houser SR. [Na+]i handling in the failing human heart. Cardiovasc Res 2003;57:874-886.
51. Wei SK, Ruknudin A, Hanlon SU, McCurley JM, Schulze DH, Haigney MC. Protein kinase A hyperphosphorylation increases basal current but decreases beta-adrenergic responsiveness of the sarcolemmal Na+-Ca2+ exchanger in failing pig myocytes. Circ Res 2003;92:897-903.
52. Day SM, Westfall MV, Metzger JM. Tuning cardiac performance in ischemic heart disease and failure by modulating myofilament function. J Mol Med 2007;85:911-921.
53. Bassani JW, Bassani RA, Bers DM. Calibration of indo-1 and resting intracellular [Ca]i in intact rabbit cardiac myocytes. Biophys J 1995;68:1453-1460.
54. Levi AJ, Li J, Spitzer KW, Bridge JH. Effect on the indo-1 transient of applying Ca2+ channel blocker for a single beat in voltage-clamped guinea-pig cardiac myocytes. J Physiol 1996;494:653-673.